HIVandHepatitis.com
 Google Custom Search

HCV - Insulin Resistance / Diabetes

Sustained Response to Interferon-based Therapy Reduces Risk of Diabetes in Hepatitis C Patients - 4/21/09

Insulin-sensitizing Agent Pioglitazone (Actos) Did Not Improve Response to Re-treatment with Pegylated Interferon plus Ribavirin - 8/29/2008

Obesity and Diabetes Are Linked to Increased Risk of Liver Cancer - 7/18/08

Insulin Resistance and Diabetes Increase the Risk of Liver Fibrosis and Hepatocellular Carcinoma in People with Chronic Hepatitis C - 7/04/08

Sustained Response to Interferon-based Therapy Reduces the Likelihood of Type 2 Diabetes - 6/24/08

Insulin Resistance and Diabetes Increase the Risk of Liver Fibrosis and Hepatocellular Carcinoma in People with Chronic Hepatitis C - 6/24/08

Sustained Response to Interferon-based Therapy Reduces the Likelihood of Type 2 Diabetes - 6/24/08

Insulin Resistance is a Risk Factor for Liver Fibrosis Even without Steatosis - 2/29/08

Insulin Resistance Linked to Lower Treatment Response in Genotype 2/3 Patients - 2/01/08

Community-based Study in Taiwan Provides More Evidence of Link between Hepatitis C and Type 2 Diabetes    - 8/17/07

Insulin Resistance and Liver Injury in Hepatitis C Patients Are Not Associated with Virus-Specific Changes in Adipocytokines    - 7/17/07

Hepatitis C Viremia, but Not Hepatitis B, Is Associated with Increased Diabetes Risk    - 7/17/07